Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity

NCT00004658 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

5'-Nucleotidase Syndrome

Interventions

DRUG: ribose
DRUG: thymidine
DRUG: uridine

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]